Invention Grant
- Patent Title: Compounds for the treatment of mTOR pathway related diseases
-
Application No.: US15613635Application Date: 2017-06-05
-
Publication No.: US10053422B2Publication Date: 2018-08-21
- Inventor: Mohammad Hossein Pourgholami , David L. Morris , Roger Aston
- Applicant: Pitney Pharmaceuticals Pty Limited
- Applicant Address: AU Kogarah
- Assignee: Pitney Pharmaceuticals Pty Limited
- Current Assignee: Pitney Pharmaceuticals Pty Limited
- Current Assignee Address: AU Kogarah
- Agency: Kilpatrick Townsend & Stockton LLP
- Priority: AU2012903365 20120806
- Main IPC: A61K31/275
- IPC: A61K31/275 ; C07C255/00 ; C07C323/62 ; A61K31/277 ; C07C255/62 ; C07C317/44 ; C07C255/29
Abstract:
The present invention relates to compounds for the treatment of mTOR (mammalian Target Of Rapamycin) pathway related diseases. Specifically, the present invention relates to the use of aminoacetonitrile derivatives (AADs) in the treatment of mTOR pathway related diseases.
Public/Granted literature
- US20170369435A1 COMPOUNDS FOR THE TREATMENT OF MTOR PATHWAY RELATED DISEASES Public/Granted day:2017-12-28
Information query
